Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9394
Title: A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
Austin Authors: Houlihan, Christine A ;Allen, Terri J;Baxter, Amynta L;Panangiotopoulos, Sianna;Casley, David J;Cooper, Mark E;Jerums, George 
Affiliation: Endocrine Unit and Department of Medicine, University of Melbourne, Austin, Australia
Issue Date: 1-Apr-2002
Publication information: Diabetes Care; 25(4): 663-71
Abstract: Diabetic subjects have a high prevalence of hypertension, increased total body exchangeable sodium levels, and an impaired ability to excrete a sodium load. This study assessed the effect of dietary sodium restriction on the efficacy of losartan in hypertensive subjects with type 2 diabetes and albumin excretion rates of 10-200 microg/min.In this study, 20 subjects were randomized to losartan 50 mg/day (n = 10) or placebo (n = 10). Drug therapy was given in two 4-week phases separated by a washout period. In the last 2 weeks of each phase, patients were assigned to low- or regular-sodium diets, in random order. In each phase, 24-h ambulatory blood pressure, urinary albumin-to-creatinine ratio (ACR), and renal hemodynamics were measured.Achieved urinary sodium on a low-sodium diet was 85 +/- 14 and 80 +/- 22 mmol/day in the losartan and placebo groups, respectively. In the losartan group, the additional blood pressure-lowering effects of a low-sodium diet compared with a regular-sodium diet for 24-h systolic, diastolic, and mean arterial blood pressures were 9.7 mmHg (95% confidence interval [CI], 2.2-17.2; P = 0.002), 5.5 mmHg (2.6-8.4; P = 0.002), and 7.3 mmHg (3.3- 11.3; P = 0.003), respectively. In the losartan group, the ACR decreased significantly on a low-sodium diet versus on a regular-sodium diet (-29% [CI -50.0 to -8.5%] vs. + 14% [-19.4 to 47.9%], respectively; P = 0.02). There was a strong correlation between fall in blood pressure and percent reduction in the ACR (r = 0.7, P = 0.02). In the placebo group, there were no significant changes in blood pressure or ACR between regular- and low-sodium diets. There were no significant changes in renal hemodynamics in either group.These data demonstrated that a low-sodium diet potentiates the antihypertensive and antiproteinuric effects of losartan in type 2 diabetes. The blood pressure reduction resulting from the addition of a low-sodium diet to losartan was of similar magnitude to that predicted from the addition of a second antihypertensive agent.
Gov't Doc #: 11919122
URI: https://ahro.austin.org.au/austinjspui/handle/1/9394
Journal: Diabetes Care
URL: https://pubmed.ncbi.nlm.nih.gov/11919122
Type: Journal Article
Subjects: Albuminuria
Aldosterone.blood
Angiotensin II.metabolism
Antihypertensive Agents.diagnostic use
Blood Glucose.metabolism
Blood Pressure.drug effects
Creatinine.blood
Diabetes Mellitus, Type 2.drug therapy.physiopathology
Diet, Sodium-Restricted
Drug Synergism
Female
Hemodynamics.drug effects.physiology
Humans
Losartan.therapeutic use
Male
Middle Aged
Placebos
Renal Circulation.drug effects.physiology
Renin.blood
Sodium.urine
Appears in Collections:Journal articles

Show full item record

Page view(s)

34
checked on Nov 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.